Objective: To analyze the dynamics of the condition of the mucous membrane in patients with metabolic syndrome at the stage of preparation for dental prosthetics using dental implants.
Material And Methods: 255 patients (151 women and 104 men) aged from 35 to 65 years were examined. 3 groups were formed: 2 study groups and a comparison group.
It has been shown that yttria-stabilized zirconia is an effective catalyst for ethanol to -butanol Guerbet coupling. The variation of the calcination temperature allows an improvement in the catalytic characteristics of this material via stabilization of the tetragonal phase of zirconia, having higher basicity than the monoclinic one. The treatment of yttria-stabilized zirconia at an optimal calcination temperature of 500 °C induces the increase in surface basicity required for the aldol condensation step, along with a decrease in surface acidity, which is responsible for the side reaction such as ethylene formation.
View Article and Find Full Text PDFObjectives: To evaluate healthcare resource (HR) consumption associated with Systemic Lupus Erythematosus (SLE) management in adult patients with active autoantibody positive disease in the Russian Federation, Republic of Kazakhstan, and Ukraine.
Methods: The ESSENCE was a retrospective, observational study, and included data on patients' clinical characteristics and SLE-related HR use (laboratory, biopsy, imaging tests, medications, visits to specialists, outpatient visits, hospitalizations) during 2010 from the 12 specialized rheumatologic centers.
Results: A total of 436 SLE patients were included in the analyses, with 232 patients being enrolled in Russia, 110 in Kazakhstan, and 94 in Ukraine.
Silver has been identified in the framework of AgSiBEA zeolites (where x = 3-6 Ag wt%) by the combined use of XRD, Ag MAS NMR, FTIR, diffuse reflectance UV-visible, EPR and XPS spectroscopy. The incorporation of Ag ions into the framework of SiBEA zeolite has been evidenced by XRD. The consumption of OH groups as a result of their reaction with the silver precursor has been monitored by FTIR and photoluminescence spectroscopy.
View Article and Find Full Text PDFAim: TO assess the effects of rituximab (RTM) therapy on clinical and morphologic activity of lupus nephritis (LN).
Material And Methods: The study included 45 patients with confirmed diagnosis of systemic lupus erythematosus (SLE), unaffected by previously received standard therapy with glucocorticoids (GCs) and cytostatics. The disease activity was assessed using Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI 2K); to assess the LN activity we used the SLICC RA/RE index.